BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10081339)

  • 1. [Heart failure and treatment of ventricular arrhythmias].
    Junga G; Duru F; Candinas R
    Praxis (Bern 1994); 1999 Feb; 88(6):215-22. PubMed ID: 10081339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blocking agents vs. antiarrhythmic interventions in heart failure complicated by arrhythmias.
    Meinertz T; Hofmann T; Zehender M; Drexler H; Hohnloser S; Just H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S151-7. PubMed ID: 11527120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiarrhythmia agents in heart failure].
    Duc P
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):595-8. PubMed ID: 7487307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiarrhythmic agents in the prevention of sudden cardiac death].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose amiodarone in severe chronic heart failure.
    Biswas A; Dey SK; Banerjee AK; Roy S; Biswas PK; Chowdhury GK; Khan AK; Mitra KK; Chatterjee SS; Maity AK
    Indian Heart J; 1996; 48(4):361-4. PubMed ID: 8908821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arrhythmia and anti-arrhythmia therapy as prognostic risks].
    Meinertz T; Zehender M; Hofmann T; Hohnloser S; Just H
    Herz; 1991 Sep; 16 Spec No 1():314-7, 323. PubMed ID: 1820298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone in congestive heart failure.
    Singh S
    Int J Clin Pract; 1998 Sep; 52(6):432-5. PubMed ID: 9894384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers, ventricular arrhythmias, and sudden death in heart failure: not as simple as it seems.
    Mcmurray J
    Eur Heart J; 2000 Aug; 21(15):1214-5. PubMed ID: 10924310
    [No Abstract]   [Full Text] [Related]  

  • 14. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac insufficiency: prevention of ventricular arrhythmias].
    Mabo P; Leclercq C; Pavin D
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():23-8. PubMed ID: 10830085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart arrhythmias and congestive heart failure].
    Abuladze GV; Narciia EV; Mamamtavrishvili ND; Nikolaishvili MG; Kantariia DA
    Georgian Med News; 2006 Apr; (133):41-4. PubMed ID: 16705224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class III drugs and congestive heart failure: focus on the congestive heart failure-survival trial of antiarrhythmic therapy.
    Singh SN; Fletcher RD
    Am J Cardiol; 1999 Nov; 84(9A):103R-108R. PubMed ID: 10568668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effects of amiodarone and metoprolol on chronic heart failure complicated by ventricular arrhythmia].
    Lü HS; He BB; Huang GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1240-2. PubMed ID: 19726373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial hypertension and cardiac arrhythmias].
    Vester EG
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.